Find Clinical Trials | Cedars-Sinai

151 results found

Other Hematopoietic

Zanubrutinib in Mantle Cell Lymphoma

This study focuses on individuals who have mantle cell lymphoma, which is a type of non-Hodgkin lymphoma. Zanubrutib is a drug approved by the U.S. Food and Drug Administration (FDA) for use in mantle cell ...

Urinary Bladder

Bladder Cancer: TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical BCG

This study focuses on individuals who have a diagnosis of high-risk, non-muscle invasive bladder cancer (also referred to as HR-NMIBC or urothelial cancer). The purpose of the study is to compare the effects of ...

Hodgkin's Lymphoma, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia ...

Collecting and Combining Autologous Hematopoietic Stem Cells With (CAR) T-Cell Therapy in Hematological Malignancies

The purpose of this study is to assess the impact of adding blood stem cells to CAR T-cell therapy in an effort to improve cancer treatment. CAR T-cell therapy is a type of treatment in ...

Bones and Joints, Breast, Cervix, Colon, Kidney, Liver, Lung, Melanoma ...

PARG Inhibitor IDE161 in Advanced Solid Tumors

This study focuses on individuals who have a solid tumor cancer (not a blood cancer) that has worsened and has not responded to at least one prior cancer treatment. The purpose of the study is ...

Other Hematopoietic

Addition of Targeted Therapeutic Agents to Tafasitamab-Based Therapy in Large B-Cell Lymphoma

This study focuses on patients with relapsed or refractory large b-cell lymphoma (LBCL). Relapsed means the LBCL has returned after it responded to treatment; refractory means the LBCL did not respond to earlier treatment. The ...